.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
This European propensity-matched study compared minimally invasive distal pancreatectomy with open surgery for pancreatic ductal adenocarcinoma. After adjustment for baseline differences, minimally invasive surgery was associated with several short-term advantages while maintaining broadly comparable oncological outcomes in appropriately selected patients. The findings support the feasibility of laparoscopy in distal pancreatic resection when performed in experienced centers with careful patient selection. For HPB surgeons, the important point is that minimally invasive pancreatic surgery should not be assessed only by whether an operation can be completed laparoscopically. Key outcomes include margin status, lymph-node harvest, postoperative pancreatic fistula, length of stay, morbidity and long-term cancer control. The study therefore supports adoption within structured HPB programs rather than indiscriminate expansion. Surgeons should also recognize that open conversion remains an acceptable safety decision when anatomy, tumor involvement or bleeding makes minimally invasive continuation unsafe. The evidence helps define minimally invasive distal pancreatectomy as a credible option within expert multidisciplinary pancreatic surgery services.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
This European propensity-matched study compared minimally invasive distal pancreatectomy with open surgery for pancreatic ductal adenocarcinoma. After adjustment for baseline differences, minimally invasive surgery was associated with several short-term advantages while maintaining broadly comparable oncological outcomes in appropriately selected patients. The findings support the feasibility of laparoscopy in distal pancreatic resection when performed in experienced centers with careful patient selection. For HPB surgeons, the important point is that minimally invasive pancreatic surgery should not be assessed only by whether an operation can be completed laparoscopically. Key outcomes include margin status, lymph-node harvest, postoperative pancreatic fistula, length of stay, morbidity and long-term cancer control. The study therefore supports adoption within structured HPB programs rather than indiscriminate expansion. Surgeons should also recognize that open conversion remains an acceptable safety decision when anatomy, tumor involvement or bleeding makes minimally invasive continuation unsafe. The evidence helps define minimally invasive distal pancreatectomy as a credible option within expert multidisciplinary pancreatic surgery services.
Yesterday
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
